PICSAR
gene geneOn this page
Also known as NLC1-CPRED74lnc-NLC1-C
Summary
PICSAR (P38 inhibited cutaneous squamous cell carcinoma associated lincRNA, HGNC:19725) is a long non-coding RNA gene on chromosome 21q22.3.
At a glance
- Gene type: non-coding (lncRNA) — no protein product.
- GTEx eGene: eQTL in 19 tissues, sQTL in 1 (q < 0.05)
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:19725 |
| Approved symbol | PICSAR |
| Name | P38 inhibited cutaneous squamous cell carcinoma associated lincRNA |
| Location | 21q22.3 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | NLC1-C, PRED74, lnc-NLC1-C |
| Ensembl gene | ENSG00000275874 |
| Ensembl biotype | lncRNA |
| OMIM | 617191 |
| Entrez | 378825 |
| RNAcentral | URS000075EA8F — lncRNA, 749 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 9 lncRNA
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 1
ENST00000615826, ENST00000758108, ENST00000758109, ENST00000758110, ENST00000758111, ENST00000758112, ENST00000758113, ENST00000758114, ENST00000758115
RefSeq mRNA: 0
Canonical transcript exons
ENST00000615826 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00004109850 | 44999140 | 44999656 |
| ENSE00004109852 | 45004444 | 45004753 |
Expression profiles
Bgee: expression breadth ubiquitous, 124 present calls, max score 74.77.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.5864 / max 54.2742, expressed in 113 samples.
Highest expression (Bgee): C1 segment of cervical spinal cord, skin of leg, skin of abdomen, spinal cord, lung.
Genetic regulation across tissues (GTEx eQTL / sQTL)
PICSAR is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 19 tissues and its splicing (sQTL) in 1 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
20 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Adipose Visceral Omentum | eqtl | 2.3e-20 | -0.53 | 21:45008193:C:G |
| Testis | eqtl | 1.4e-17 | -0.62 | 21:45008193:C:G |
| Spleen | eqtl | 2.7e-14 | -0.84 | 21:45008193:C:G |
| Brain Spinal cord cervical c-1 | eqtl | 4.2e-14 | -0.92 | 21:45008433:C:A |
| Lung | eqtl | 2.8e-13 | -0.39 | 21:44997056:A:G |
| Brain Substantia nigra | eqtl | 3.9e-11 | -0.88 | 21:45008193:C:G |
| Brain Caudate basal ganglia | eqtl | 5.8e-08 | -0.47 | 21:45004654:C:T |
| Skin Sun Exposed Lower leg | eqtl | 6.8e-07 | -0.26 | 21:45018967:C:G |
| Brain Hypothalamus | eqtl | 9.1e-07 | -0.53 | 21:45008433:C:A |
| Brain Putamen basal ganglia | eqtl | 1.4e-06 | -0.50 | 21:45004654:C:T |
| Artery Tibial | eqtl | 1.7e-06 | -0.31 | 21:45008046:C:T |
| Esophagus Muscularis | eqtl | 2.2e-06 | +0.29 | 21:45043170:C:T |
| Skin Not Sun Exposed Suprapubic | eqtl | 3.7e-06 | -0.28 | 21:45018967:C:G |
| Artery Aorta | eqtl | 7.7e-06 | -0.38 | 21:45008046:C:T |
| Brain Hippocampus | eqtl | 7.7e-06 | -0.53 | 21:45008193:C:G |
| Esophagus Mucosa | eqtl | 3.8e-05 | +0.35 | 21:45000840:C:A |
| Artery Coronary | eqtl | 5.8e-05 | -0.46 | 21:45008193:C:G |
| Breast Mammary Tissue | eqtl | 2.3e-03 | -0.18 | 21:44990923:T:C |
| Artery Aorta | sqtl | 3.1e-02 | -1.04 | 21:44997153:TGGGGAGGAAGGTGGGTACCCC:T |
| Brain Nucleus accumbens basal ganglia | eqtl | 4.9e-02 | -0.31 | 21:45000109:C:T |
FANTOM5 promoters
4 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 190815 | 0.3047 | 83 |
| 190813 | 0.1210 | 51 |
| 190814 | 0.0984 | 49 |
| 190816 | 0.0623 | 36 |
Top tissues by expression
showing 100 of 219 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| C1 segment of cervical spinal cord | UBERON:0006469 | 74.77 | gold quality |
| skin of leg | UBERON:0001511 | 73.03 | gold quality |
| skin of abdomen | UBERON:0001416 | 72.43 | gold quality |
| spinal cord | UBERON:0002240 | 71.66 | gold quality |
| right lung | UBERON:0002167 | 70.14 | gold quality |
| zone of skin | UBERON:0000014 | 69.00 | gold quality |
| left testis | UBERON:0004533 | 66.80 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 66.07 | gold quality |
| popliteal artery | UBERON:0002250 | 65.60 | gold quality |
| tibial artery | UBERON:0007610 | 65.56 | gold quality |
| aorta | UBERON:0000947 | 65.33 | gold quality |
| thoracic aorta | UBERON:0001515 | 65.30 | gold quality |
| ascending aorta | UBERON:0001496 | 65.18 | gold quality |
| testis | UBERON:0000473 | 64.14 | gold quality |
| left coronary artery | UBERON:0001626 | 63.76 | gold quality |
| mucosa of stomach | UBERON:0001199 | 63.24 | gold quality |
| lower esophagus | UBERON:0013473 | 62.93 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 62.92 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 62.89 | gold quality |
| right coronary artery | UBERON:0001625 | 62.78 | gold quality |
| coronary artery | UBERON:0001621 | 62.28 | gold quality |
| right testis | UBERON:0004534 | 61.54 | gold quality |
| upper lobe of lung | UBERON:0008948 | 61.08 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 60.56 | gold quality |
| calcaneal tendon | UBERON:0003701 | 57.08 | gold quality |
| gall bladder | UBERON:0002110 | 56.89 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 56.88 | gold quality |
| esophagus | UBERON:0001043 | 56.42 | gold quality |
| left uterine tube | UBERON:0001303 | 56.22 | gold quality |
| lung | UBERON:0002048 | 55.51 | gold quality |
| omental fat pad | UBERON:0010414 | 55.48 | gold quality |
| peritoneum | UBERON:0002358 | 55.42 | gold quality |
| prefrontal cortex | UBERON:0000451 | 54.78 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 54.33 | gold quality |
| substantia nigra | UBERON:0002038 | 53.61 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 53.47 | gold quality |
| corpus callosum | UBERON:0002336 | 53.34 | gold quality |
| vermiform appendix | UBERON:0001154 | 52.97 | gold quality |
| anatomical system | UBERON:0000467 | 52.44 | gold quality |
| minor salivary gland | UBERON:0001830 | 52.24 | gold quality |
| multicellular organism | UBERON:0000468 | 52.05 | gold quality |
| material anatomical entity | UBERON:0000465 | 52.03 | gold quality |
| midbrain | UBERON:0001891 | 51.86 | gold quality |
| muscle of leg | UBERON:0001383 | 50.72 | gold quality |
| mouth mucosa | UBERON:0003729 | 50.54 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 50.44 | gold quality |
| hypothalamus | UBERON:0001898 | 50.28 | gold quality |
| skin of hip | UBERON:0001554 | 50.23 | silver quality |
| heart | UBERON:0000948 | 49.96 | gold quality |
| gastrocnemius | UBERON:0001388 | 49.76 | gold quality |
| islet of Langerhans | UBERON:0000006 | 49.47 | gold quality |
| esophagus mucosa | UBERON:0002469 | 49.19 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 49.18 | gold quality |
| tendon | UBERON:0000043 | 49.08 | gold quality |
| right atrium auricular region | UBERON:0006631 | 48.81 | gold quality |
| caecum | UBERON:0001153 | 48.23 | gold quality |
| cardiac atrium | UBERON:0002081 | 48.18 | gold quality |
| monocyte | CL:0000576 | 48.01 | silver quality |
| caudate nucleus | UBERON:0001873 | 47.75 | gold quality |
| right ovary | UBERON:0002118 | 47.42 | gold quality |
| Ammon’s horn | UBERON:0001954 | 47.39 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 47.10 | gold quality |
| adipose tissue | UBERON:0001013 | 46.91 | gold quality |
| body of stomach | UBERON:0001161 | 46.78 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 46.66 | gold quality |
| stomach | UBERON:0000945 | 46.64 | gold quality |
| ectocervix | UBERON:0012249 | 46.42 | gold quality |
| urinary bladder | UBERON:0001255 | 46.14 | gold quality |
| frontal cortex | UBERON:0001870 | 45.40 | gold quality |
| transverse colon | UBERON:0001157 | 45.35 | gold quality |
| brain | UBERON:0000955 | 45.34 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 45.25 | gold quality |
| neocortex | UBERON:0001950 | 45.24 | gold quality |
| fundus of stomach | UBERON:0001160 | 45.11 | gold quality |
| left ovary | UBERON:0002119 | 45.02 | gold quality |
| endocervix | UBERON:0000458 | 45.00 | gold quality |
| nucleus accumbens | UBERON:0001882 | 44.94 | gold quality |
| forebrain | UBERON:0001890 | 44.90 | gold quality |
| pancreas | UBERON:0001264 | 44.81 | silver quality |
| colon | UBERON:0001155 | 44.80 | gold quality |
| uterine cervix | UBERON:0000002 | 44.72 | gold quality |
| sperm | CL:0000019 | 44.55 | gold quality |
| cerebellar cortex | UBERON:0002129 | 44.54 | silver quality |
| cerebellar hemisphere | UBERON:0002245 | 44.53 | silver quality |
| large intestine | UBERON:0000059 | 44.49 | gold quality |
| amygdala | UBERON:0001876 | 44.49 | gold quality |
| cerebral cortex | UBERON:0000956 | 44.45 | gold quality |
| heart left ventricle | UBERON:0002084 | 44.29 | gold quality |
| spleen | UBERON:0002106 | 44.23 | silver quality |
| subcutaneous adipose tissue | UBERON:0002190 | 43.99 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 43.98 | silver quality |
| vagina | UBERON:0000996 | 43.94 | gold quality |
| putamen | UBERON:0001874 | 43.91 | gold quality |
| cardiac ventricle | UBERON:0002082 | 43.59 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 43.41 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| small intestine | UBERON:0002108 | 43.20 | gold quality |
| blood | UBERON:0000178 | 42.79 | gold quality |
| placenta | UBERON:0001987 | 42.77 | gold quality |
| tonsil | UBERON:0002372 | 42.73 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.96 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 8)
- The accumulation of NLC1-C in the nucleus repressed miR-320a and miR-383 transcript and promoted testicular embryonal carcinoma cell proliferation by binding to Nucleolin. (PMID:26539909)
- PICSAR has a role in promoting cSCC progression via activation of extracellular signal-regulated kinase 1/2 signaling pathway by downregulating DUSP6 expression (PMID:27049681)
- LINC00162 overexpression increased the sensitivity, enhanced cell cycle arrest and apoptosis induced by 5-aza-dC, but did not affect its DNA demethylation effect. Mechanistically, LINC00162 interacted with an RNA splicing protein, HNRNPH1, and decreased splicing of an anti-apoptotic splicing variant, BCL-XL. LINC00162 may have translational value to predict patients who will respond to 5-aza-dC. (PMID:30914798)
- Our results reveal PICSAR may exert an essential role in promoting synovial invasion and joint destruction by sponging miR-4701-5p in RA and that lncRNA PICSAR may act as a biomarker of RA. (PMID:31791845)
- Long non-coding RNA PICSAR knockdown inhibits the progression of cutaneous squamous cell carcinoma by regulating miR-125b/YAP1 axis. (PMID:32841663)
- LncRNA PICSAR binds to miR-485-5p and activates TGF-beta1/Smad to promote abnormal proliferation of hypertrophic scar fibroblasts (HSFs) and excessive deposition of extracellular matrix (ECM). (PMID:34255190)
- LINC00162 regulates cell proliferation and apoptosis by sponging PAQR4-targeting miR-485-5p. (PMID:35491694)
- Long Intergenic Non-Coding 00162 as Diagnostic Biomarker for Early-Stage Pancreatic Cancer. (PMID:36197769)
Cross-species orthologs
0 orthologs
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| LINC00334 | ncRNA | 114042 |
| POFUT2 | protein-coding | 23275 |
| ADARB1 | protein-coding | 104 |
| LINC00165 | ncRNA | 727701 |
| LINC00163 | ncRNA | 727699 |
| ITGB2-AS1 | ncRNA | 100505746 |
| ITGB2 | protein-coding | 3689 |
| LINC01547 | ncRNA | 84536 |
| SLX9 | protein-coding | 85395 |
Protein
Non-coding RNA — no protein product.
Function
Gene-set membership (MSigDB)
This non-coding RNA is a member of 7 curated MSigDB gene sets — regulatory-target and signature collections that include it (it has no protein-based pathway / GO / interaction data).
chr21q22, HMGA1_TARGET_GENES, TFEB_TARGET_GENES, GSE13485_CTRL_VS_DAY1_YF17D_VACCINE_PBMC_DN, ZNF320_TARGET_GENES, GSE26928_EFF_MEM_VS_CENTR_MEM_CD4_TCELL_DN, GSE16385_IFNG_TNF_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN
ncRNA interactions
Experimentally supported non-coding-RNA interaction partners (NPInter).
showing 8 of 14 interaction partners:
| Partner | Partner type | Level | Source |
|---|---|---|---|
| LINC00162 | lncRNA | RNA-Protein | GSE111188 |
| ICP27 | protein | RNA-Protein | High-throughput data |
| EWSR1 | protein | RNA-Protein | High-throughput data |
| IGF2BP3 | protein | RNA-Protein | High-throughput data |
| IGF2BP1 | protein | RNA-Protein | High-throughput data |
| DHX36 | protein | RNA-Protein | High-throughput data |
| miR-125b | miRNA | RNA-RNA | Literature mining |
| miR-485-5p | miRNA | RNA-RNA | Literature mining |
Disease & clinical
ncRNA disease associations
Curated non-coding-RNA → disease associations (LncRNADisease, HMDD) — these are RNA-level associations for this gene, not the positional variant data omitted above.
6 ncRNA–disease associations:
| Disease | Causal? | Validated by |
|---|---|---|
| Carcinoma, Hepatocellular | Yes | IHC, Western Blot, Flow Cytometry, qRT-PCR, RIP, Luciferase Report Assay, Colony Formation Assay, EdU Staining |
| Skin Neoplasms | No | qRT-PCR |
| Glioma | Yes | Western Blot, Transfection, Migration Assay, qRT-PCR, Cell Proliferation Assay, Cell Cycle Assay, Invasion Assay |
| Urinary Bladder Neoplasms | Yes | Flow Cytometry, qRT-PCR, RNA Pull-Down, RIP |
| pancreatic ductal adenocarcinoma | Yes | qRT-PCR, RNA-seq |
| Skin Neoplasms | Yes | Western Blot, CCK8, qRT-PCR, Flow Cytometry, RIP, Luciferase Report Assay, Transwell Assay |
Drugs & pharmacology
ncRNA–drug associations
Curated non-coding-RNA → drug associations (drug response / resistance / target).
2 ncRNA–drug associations:
| Drug | Relation | Effect | Condition |
|---|---|---|---|
| Decitabine | drug_resistance | sensitive | “cell line (HSC41, HSC44)” |
| Temozolomide | drug_resistance | sensitive | cell line (U251) |
Related Atlas pages
- Associated diseases (ncRNA): skin neoplasm, glioma, urinary bladder neoplasm, pancreatic ductal adenocarcinoma
- Associated drugs (ncRNA: response / resistance): Decitabine, Temozolomide